184 related articles for article (PubMed ID: 34344098)
1. [Primary experience and discussion on the treatment of esthesioneuroblastoma].
Jiang LJ; Lin TJ; Huang ZQ; Zuo KJ; Zhang Y; Shi JB; Lai YY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Jul; 56(7):719-723. PubMed ID: 34344098
[No Abstract] [Full Text] [Related]
2. [New system combining Hyams grading system and modified Kadish stage to evaluate the progress of esthesioneuroblastoma].
Lai YY; Lin TJ; Jiang LJ; Deng J; Zuo KJ; Zhang Y; Shi JB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):599-602. PubMed ID: 31327194
[No Abstract] [Full Text] [Related]
3. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes.
Bell D; Saade R; Roberts D; Ow TJ; Kupferman M; DeMonte F; Hanna EY
Head Neck Pathol; 2015 Mar; 9(1):51-9. PubMed ID: 24806334
[TBL] [Abstract][Full Text] [Related]
4. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.
Miyamoto RC; Gleich LL; Biddinger PW; Gluckman JL
Laryngoscope; 2000 Aug; 110(8):1262-5. PubMed ID: 10942123
[TBL] [Abstract][Full Text] [Related]
5. Consolidating the Hyams grading system in esthesioneuroblastoma - an individual participant data meta-analysis.
Vuong HG; Ngo TNM; Dunn IF
J Neurooncol; 2021 May; 153(1):15-22. PubMed ID: 33770323
[TBL] [Abstract][Full Text] [Related]
6. [A retrospective study about 11 cases of Esthesioneuroblastomas treated in Hospital Santa Creu i Sant Pau between 2000 and 2008 and literature review].
Muñoz F; Tresserras P; Montserrat JR; Sancho FJ; Bartumeus F
Neurocirugia (Astur); 2011 Oct; 22(5):401-17; discussion 417-8. PubMed ID: 22031159
[TBL] [Abstract][Full Text] [Related]
7. Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome.
Malouf GG; Casiraghi O; Deutsch E; Guigay J; Temam S; Bourhis J
Eur J Cancer; 2013 Apr; 49(6):1324-34. PubMed ID: 23312882
[TBL] [Abstract][Full Text] [Related]
8. Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients.
Xiong L; Zeng XL; Guo CK; Liu AW; Huang L
BMC Cancer; 2017 Apr; 17(1):254. PubMed ID: 28399835
[TBL] [Abstract][Full Text] [Related]
9. Proposal of a TNM classification-based staging system for esthesioneuroblastoma: More precise prediction of prognosis.
Sun M; Wang K; Qu Y; Zhang J; Zhang S; Chen X; Wang J; Wu R; Zhang Y; Yi J; Xiao J; Xu G; Huang X; Luo J
Head Neck; 2021 Apr; 43(4):1097-1104. PubMed ID: 33301222
[TBL] [Abstract][Full Text] [Related]
10. Long-term analysis of multimodality treatment outcomes and prognosis of esthesioneuroblastomas: a single center results of 138 patients.
Sun M; Wang K; Qu Y; Zhang J; Zhang S; Chen X; Wang J; Wu R; Zhang Y; Yi J; Xiao J; Xu G; Huang X; Luo J
Radiat Oncol; 2020 Sep; 15(1):219. PubMed ID: 32948223
[TBL] [Abstract][Full Text] [Related]
11. [Long-term experiences in the therapy of esthesioneuroblastoma].
Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
[TBL] [Abstract][Full Text] [Related]
12. Combined modality therapy of esthesioneuroblastoma.
McLean JN; Nunley SR; Klass C; Moore C; Müller S; Johnstone PA
Otolaryngol Head Neck Surg; 2007 Jun; 136(6):998-1002. PubMed ID: 17547995
[TBL] [Abstract][Full Text] [Related]
13. Esthesioneuroblastoma: a Danish demographic study of 40 patients registered between 1978 and 2000.
Theilgaard SA; Buchwald C; Ingeholm P; Kornum Larsen S; Eriksen JG; Sand Hansen H
Acta Otolaryngol; 2003 Apr; 123(3):433-9. PubMed ID: 12737303
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of 31 cases of esthesioneuroblastoma].
He X; Wang Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Apr; 35(4):338-340. PubMed ID: 33794633
[No Abstract] [Full Text] [Related]
15. Prognostic significance of Kadish staging in esthesioneuroblastoma: An analysis of the National Cancer Database.
Konuthula N; Iloreta AM; Miles B; Rhome R; Ozbek U; Genden EM; Posner M; Misiukiewicz K; Govindaraj S; Shrivastava R; Gupta V; Bakst RL
Head Neck; 2017 Oct; 39(10):1962-1968. PubMed ID: 28815831
[TBL] [Abstract][Full Text] [Related]
16. Multicenter Survival Analysis and Application of an Olfactory Neuroblastoma Staging Modification Incorporating Hyams Grade.
Choby G; Geltzeiler M; Almeida JP; Champagne PO; Chan E; Ciporen J; Chaskes MB; Fernandez-Miranda J; Gardner P; Hwang P; Ji KSY; Kalyvas A; Kong KA; McMillan R; Nayak J; O'Byrne J; Patel C; Patel Z; Peris Celda M; Pinheiro-Neto C; Sanusi O; Snyderman C; Thorp BD; Van Gompel JJ; Young SC; Zenonos G; Zwagerman NT; Wang EW
JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):837-844. PubMed ID: 37535372
[TBL] [Abstract][Full Text] [Related]
17. Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma.
Joshi RR; Husain Q; Roman BR; Cracchiolo J; Yu Y; Tsai J; Kang J; McBride S; Lee NY; Morris L; Ganly I; Tabar V; Cohen MA
J Surg Oncol; 2019 Jan; 119(1):130-142. PubMed ID: 30466166
[TBL] [Abstract][Full Text] [Related]
18. Esthesioneuroblastoma - a clinicopathologic study and role of DNA topoisomerase alpha.
Sharma S; Sharma MC; Johnson MH; Lou M; Thakar A; Sarkar C
Pathol Oncol Res; 2007; 13(2):123-9. PubMed ID: 17607373
[TBL] [Abstract][Full Text] [Related]
19. Long-term oncologic outcomes in esthesioneuroblastoma: An institutional experience of 143 patients.
McMillan RA; Van Gompel JJ; Link MJ; Moore EJ; Price DL; Stokken JK; Van Abel KM; O'Byrne J; Giannini C; Chintakuntlawar A; Pinheiro Neto CD; Peris Celda M; Foote R; Choby G
Int Forum Allergy Rhinol; 2022 Dec; 12(12):1457-1467. PubMed ID: 35385606
[TBL] [Abstract][Full Text] [Related]
20. Microvessel density and Ki-67 labeling index in esthesioneuroblastoma: is there a prognostic role?
Singh L; Ranjan R; Madan R; Arava SK; Deepak RK; Singh MK
Ann Diagn Pathol; 2015 Dec; 19(6):391-6. PubMed ID: 26343569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]